+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Friedreich's Ataxia Clinical Trial Pipeline Highlights - 2019

  • ID: 4773941
  • Report
  • March 2019
  • Region: Global
  • Fore Pharma
1 of 2
This report, Friedreich's Ataxia Pipeline Highlights - 2019, provides most up-to-date information on key pipeline products in the global Friedreich's Ataxia market. It covers emerging therapies for Friedreich's Ataxia in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

Clinical Trial Stages:

The report provides Friedreich's Ataxia pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

Drug Mechanism Classes:

The report provides Friedreich's Ataxia pipeline products by their dominant mechanism of action/drug class. This helps executives categorize products based on their drug class and also assess the strengths and weaknesses of compounds.

Company:

The report provides Friedreich's Ataxia pipeline products by the company.

Short-term Launch Highlights:

Find out which Friedreich's Ataxia pipeline products will be launched in the US and Ex-US till 2024.

Summary:
  • Friedreich's Ataxia phase 3 clinical trial pipeline products
  • Friedreich's Ataxia phase 2 clinical trial pipeline products
  • Friedreich's Ataxia phase 1 clinical trial pipeline products
  • Friedreich's Ataxia preclinical research pipeline products
  • Friedreich's Ataxia discovery stage pipeline products
  • Friedreich's Ataxia pipeline products short-term launch highlights

Note: Please allow up to 48 hours for delivery after order is placed.
Please Note: This report will be delivered within 2 business days of ordering.
Note: Product cover images may vary from those shown
2 of 2
1. Friedreich's Ataxia Pipeline by Stages

2. Friedreich's Ataxia Phase 3 Clinical Trial Insights

3. Friedreich's Ataxia Phase 2 Clinical Trial Insights

4. Friedreich's Ataxia Phase 1 Clinical Trial Insights

5. Friedreich's Ataxia Preclinical Research Insights

6. Friedreich's Ataxia Discovery Stage Insights

7. Appendix

8. Research Methodology

List of Tables:
Table 1: Friedreich's Ataxia Phase 3 Clinical Trials, 2019
Table 2: Friedreich's Ataxia Phase 2 Clinical Trials, 2019
Table 3: Friedreich's Ataxia Phase 1 Clinical Trials, 2019
Table 4: Friedreich's Ataxia Preclinical Research, 2019
Table 5: Friedreich's Ataxia Discovery Stage, 2019

List of Figures:
Figure 1:: Friedreich's Ataxia Pipeline Molecules by Clinical Trials Stage, 2019
Figure 2: Friedreich's Ataxia Phase 3 Clinical Trial Highlights, 2019
Figure 3: Friedreich's Ataxia Phase 2 Clinical Trial Highlights, 2019
Figure 4: Friedreich's Ataxia Phase 1 Clinical Trial Highlights, 2019
Figure 5: Friedreich's Ataxia Preclinical Research Highlights, 2019
Figure 6: Friedreich's Ataxia Discovery Stage Highlights, 2019
Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Adroll
adroll